OmniMetrix

Product

Last mentioned: Mar 6, 2026

Timeline

  1. Earnings Calls

    Management teams for both companies host conference calls to provide strategic updates and 2026 outlook.

  2. Transcript Release

    Full transcripts of the Q4 2025 earnings calls are made available to the public and analysts.

  3. SEC Filings

    Both ACFN and CRMD file 8-K reports detailing Q4 and full-year 2025 financial results.

Stories mentioning OmniMetrix 1

earnings Neutral

Micro-Cap Execution: Acorn Energy and CorMedix Deliver Q4 2025 Results

Acorn Energy and CorMedix both reported Q4 2025 financial results on March 5, 2026, marking a critical transition from development to commercial scaling. While Acorn focuses on high-margin IoT recurring revenue, CorMedix is navigating the complex rollout of its lead product, DefenCath, in the dialysis market.

2 sources